Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

BACKGROUND: Two standard sets of criteria are used to evaluate the tumor response of hepatocellular carcinoma (HCC): RECIST (Response Evaluation Criteria in Solid Tumors) and modified RECIST (mRECIST). The purpose was to compare two tumor response evaluation criteria, RECIST version 1.1 and mRECIST,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yozo, Watanabe, Hirokazu, Sone, Miyuki, Onaya, Hiroaki, Sakamoto, Noriaki, Osuga, Keigo, Takahashi, Masahide, Arai, Yasuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572665/
https://www.ncbi.nlm.nih.gov/pubmed/23167460
http://dx.doi.org/10.3109/03009734.2012.729104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572665/
https://www.ncbi.nlm.nih.gov/pubmed/23167460
http://dx.doi.org/10.3109/03009734.2012.729104

Ejemplares similares